Your browser doesn't support javascript.
loading
Comparative randomized trial study about the efficacy of photobiomodulation and curcumin antimicrobial photodynamic therapy as a coadjuvant treatment of oral mucositis in oncologic patients: antimicrobial, analgesic, and degree alteration effect.
de Cássia Dias Viana Andrade, Rita; Azevedo Reis, Thaís; Rosa, Luciano Pereira; de Oliveira Santos, Gabriel Pinto; da CristinaSilva, Francine.
Afiliação
  • de Cássia Dias Viana Andrade R; Cruzeiro Do Sul University, Paulista Avenue, 1415 Centro, São Paulo, São Paulo, 01311-925, Brazil.
  • Azevedo Reis T; Multidisciplinary Health Institute, Federal University of Bahia, Vitória da Conquista, Rio de Contas Street, 58 Candeias, Bahia, 450029-094, Brazil. tazevedo011@gmail.com.
  • Rosa LP; Multidisciplinary Health Institute, Federal University of Bahia, Vitória da Conquista, Rio de Contas Street, 58 Candeias, Bahia, 450029-094, Brazil.
  • de Oliveira Santos GP; Multidisciplinary Health Institute, Federal University of Bahia, Vitória da Conquista, Rio de Contas Street, 58 Candeias, Bahia, 450029-094, Brazil.
  • da CristinaSilva F; Multidisciplinary Health Institute, Federal University of Bahia, Vitória da Conquista, Rio de Contas Street, 58 Candeias, Bahia, 450029-094, Brazil.
Support Care Cancer ; 30(9): 7365-7371, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35608694
ABSTRACT

INTRODUCTION:

As conventional treatments currently available for mucositis are not considerably effective, there is a need to implement an adjuvant protocol for the treatment of oral mucositis in patients undergoing radiotherapy and chemotherapy.

PURPOSE:

To evaluate the effect of photobiomodulation (PBM) and antimicrobial photodynamic therapy (aPDT) mediated by curcumin and blue LED as an adjunct treatment of oral mucositis for oncology patients using chemotherapy and/or radiotherapy.

METHODS:

Clinical, randomized study, in a single location, in an oncology service of a general hospital, with a total of 30 patients (over 18 years old) with stable oral mucosa lesions in the process of chemotherapy and/or radiotherapy. The patients were divided into 3 groups control group (treated with nystatin), PBM group (treated with low-level laser therapy), and the aPDT group (treated with 450-nm blue LED and curcumin photosensitizer).

RESULTS:

The results showed, by means of intra-group comparisons, that the two experimental treatments promoted yeast reduction of the genus Candida in the last two evaluations (21 days and 30 days), but not in the first two evaluations (7 days and 14 days). The intra-group comparisons showed that the control and aPDT group showed a significant difference in the degree of mucositis over the four evaluations performed, with the results pointing out that the mucositis worsened in the control group from the 14th day, while reduced in the aPDT group from the 21st day of treatment.

CONCLUSION:

A reduction in the degree of mucositis and pain score was observed in the PBM and aPDT groups, with the aPDT group standing out when presenting early clinical improvement in relation to the PBM group and the control group, thus emphasizing its effectiveness within the desired aspects. Regarding the antimicrobial effect, aPDT showed a greater reduction of yeasts of the genus Candida in the tested parameters.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Estomatite / Curcumina / Mucosite / Anti-Infecciosos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Estomatite / Curcumina / Mucosite / Anti-Infecciosos Idioma: En Ano de publicação: 2022 Tipo de documento: Article